Most engineered nanoparticles enter tumours through cells, not between them

Researchers from U of T Engineering have discovered that an active, rather than passive, process dictates which nanoparticles enter solid tumors. The finding upends previous thinking in the field of cancer nanomedicine and points toward more effective nanotherapies.